Katsumasa Nagano (Nagano Katsumasa)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Clinical Practice

Rheumatoid Arthritis

Top Venues

Crohn's & colitis 360

This page only lists publications with an associated author ORCID identifier.

Publications

Katsumasa Nagano, Erina Hata, Teita Asano, Hiroaki Tsuchiya, Masayuki Takagishi, Hiroshi Yamazaki, Sonoko Tominaga, Takayuki Matsumoto
Safety and Effectiveness of Ustekinumab for Crohn's Disease in Japanese Post-marketing Surveillance in Biologic-Naive and -Experienced Conriemed. Crohn's & colitis 360 5 (1) (2023)
Katsumasa Nagano, Erina Hata, Teita Asano, Hiroaki Tsuchiya, Masayuki Takagishi, Hiroshi Yamazaki, Sonoko Tominaga, Takayuki Matsumoto
Safety and Effectiveness of Ustekinumab for Crohn's Disease in Japanese Post-marketing Surveillance in Biologic-Naive and -Experienced Conriemed. Crohn's & colitis 360 5 (1) (2023)
Katsuyoshi Matsuoka, Katsumasa Nagano, Shinya Nagasaki, Yoko Murata, Tadakazu Hisamatsu
Symptom Improvement of ulceRative colitis after an Induction dose of UStekinumab in Japanese clinical practice (SIRIUS), measured using patient-reported outcomes: a prospective observational study. BMJ open 12 (5) (2022)
Celine Miyazaki, Katsumasa Nagano, Kuan Chih Huang, Yan Fang Liu
Evaluation of economic burden with biologic treatments in Crohn's disease patients: A mirror image study using an insurance database in Japan. PloS one 16 (7) (2021)